Navigation Links
Neuroprotection - Drugs, Markets and Companies - Updated 2013 Report with Extra Company Collaborations

DUBLIN, August 9, 2013 /PRNewswire/ --

Research and Markets ( have announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" to their offering.


This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues are similar in all these conditions and several products are used in more than one disorder. Over 500 products have been investigated for neuroprotective effects including those from the categories of free radical scavengers, anti-excitotoxic agents, apoptosis (programmed cell death) inhibitors, anti-inflammatory agents, neurotrophic factors, metal ion chelators, ion channel modulators and gene therapy. Some of the agents are old established pharmaceuticals whereas others are new biotechnology products.

Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

The report contains profiles of 136 companies that have a neuroprotective product or products along with 120 collaborations. Some of the products in development at academic institutions that do not have a commercial sponsor are also included. Although an up-to-date search of the literature was performed and selected 1,000 references are included. Clinical trials of various neuroprotective agents are described and failures of trials are analyzed with suggestions for improving the selection of drugs and design of trials. The report is supplemented with 67 tables and 13 figures.

Market analysis of currently used products that have a neuroprotective effect are analyzed for the year 2012. Some of these products are approved for other indications but are known to have a neuroprotective effect. With the approval of new products and takeover of markets for obsolete symptomatic therapies, the neuroprotection market value will rise by the year 2017 when it will constitute a major and important component of the CNS market. Forecasts are made until 2022. By that time neuroprotection will be an established part of the neurological practice and measures will be available to achieve this effectively.

Key Topics Covered:

Part I: Drugs & Markets

Executive Summary

1. Introduction
2. Neuroprotective Agents
3. Neuroprotection in Cerebrovascular Disease
4. Neuroprotection in Traumatic Brain Injury
5. Neuroprotection in Spinal Cord Injury
6. Neuroprotection in Neurodegenerative Disorders
7. Neuroprotection in Parkinson Disease
8. Neuroprotection in Alzheimer Disease
9. Neuroprotection in Huntington Disease
10. Neuroprotection in Amyotrophic Lateral Sclerosis
11. Neuroprotection in Miscellaneous Neurological Disorders
12. Neuroprotection of the Optic nerve and the Retina
13. Neuroprotection during Anesthesia and Surgery
14. Markets for Neuroprotective Therapies
15. References

Part II: Companies

16. Companies Developing Neuroprotective Therapies

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Alzheimer Disease - New Drugs, Markets and Companies - 2013
2. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
3. RNAi - Technologies, Markets and Companies - Updated 2012 Report
4. Life Science Software - 2013 Market Report: Markets and Opportunities
5. Cytogenetics - Technologies, Markets and Companies - 2013
6. Biomarkers - Technologies, Markets and Companies - Updated 2012 Report
7. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
8. Next Generation Sequencing: Emerging Clinical Applications and Global Markets
9. Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles
10. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
11. DNA Sequencing: Technologies, Markets and Companies - 2013 Report
Post Your Comments:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
Breaking Biology News(10 mins):